Scientific publications

Scientific articles authored by Novo Nordisk

The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.

4303 results found.
Showing results 41-60
Journal Author Year
Diabetes Obesity and Metabolism

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

Nauck M ; Frid A ; Hermansen K ; Thomsen AB ; During M ; Shah N ; Tankova T ; Mitha I ; Matthews DR 2013
Diabetes Obesity and Metabolism

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Niswender K ; Pi-Sunyer X ; Buse J ; Jensen KH ; Toft AD ; Russell-Jones D ; Zinman B 2013
Diabetes Obesity and Metabolism

Insulin aspart has a shorter duration of action than human insulin over a wide dose-range

Nosek L ; Roggen K ; Heinemann L ; Gottschalk C ; Kaiser M ; Arnolds S ; Heise T 2013
Diabetes Obesity and Metabolism

Incretin and pancreatic hormone secretion in Caucasian non- diabetic carriers of the TCF7L2 rs7903146 risk T allele

Faerch K ; Pilgaard K ; Knop FK ; Hansen T ; Pedersen O ; Jorgensen T ; Holst JJ 2013
Diabetes Obesity and Metabolism

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

Ratner RE ; Gough SCL ; Mathieu C ; Del Prato S ; Bode B ; Mersebach H ; Endahl L ; Zinman B 2013
Diabetes Research and Clinical Practice

Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care

Peyrot M ; Burns KK ; Davies M ; Forbes A ; Hermanns N ; Holt R ; Kalra S ; Nicolucci A ; Pouwer F ; Wens J ; Willaing I ; Skovlund SE 2013
Diabetic Medicine

Urinary sulphate excretion and progression of diabetic nephropathy in Type1 diabetes

Andresdottir G ; Bakker SJL ; Hansen HP ; Parving HH ; Rossing P 2013
Diabetic Medicine

Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus

Hajos TRS ; Pouwer F ; Skovlund SE ; Den Oudsten BL ; Geelhoed-Duijvestijn PHLM ; Tack CJ ; Snoek FJ 2013
Diabetic Medicine

Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial

Thalange N ; Bereket A ; Larsen J ; Hiort LC ; Peterkova V 2013
Diabetic Medicine

Insulin degludec improves health-related quality of life (SF- 36 (R)) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials

Freemantle N ; Meneghini L ; Christensen T ; Wolden ML ; Jendle J ; Ratner R 2013
Diabetic Medicine

Recall of HbA(1c) and self-management behaviours, patient activation, perception of care and diabetes distress in Type2 diabetes

Willaing I ; Rogvi SA ; Bogelund M ; Almdal T ; Schiotz M 2013
Diabetic Medicine

Risk scores for diabetes and impaired glycaemia in the Middle East and North Africa

Handlos LN ; Witte DR ; Almdal TP ; Nielsen LB ; Badawi SE ; Sheikh ARA ; Belhadj M ; Nadir D ; Zinai S ; Vistisen D 2013
Diabetologia

Growth arrest specific protein (GAS) 6: a role in the regulation of proliferation and functional capacity of the perinatal rat beta cell

Haase TN ; Rasmussen M ; Jaksch CAM ; Gaarn LW ; Petersen CK ; Billestrup N ; Nielsen JH 2013
Diabetologia

Reassessment of the putative role of BLK-p.A71T loss-of- function mutation in MODY and type 2 diabetes

Bonnefond A ; Yengo L ; Philippe J ; Dechaume A ; Ezzidi I ; Vaillant E ; Gjesing AP ; Andersson EA ; Czernichow S ; Hercberg S ; Hadjadj S ; Charpentier G ; Lantieri O ; Balkau B ; Marre M 2013
Diabetologia

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

Roscioni SS ; de Zeeuw D ; Hellemons ME ; Mischak H ; Zurbig P ; Bakker SJL ; Gansevoort RT ; Reinhard H ; Persson F ; Lajer M ; Rossing P ; Heerspink HJL 2013
Diabetologia

Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study

Hulman A ; Faerch K ; Vistisen D ; Karsai J ; Nyari TA ; Tabak AG ; Brunner EJ ; Kivimaki M ; Witte DR 2013
Diabetologia

Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes

Albrechtsen A ; Grarup N ; Li Y ; Sparso T ; Tian G ; Cao H ; Jiang T ; Kim SY ; Korneliussen T ; Li Q ; Nie C ; Wu R ; Skotte L ; Morris AP ; Ladenvall C 2013
Diabetologia

Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes

Alkayyali S ; Lajer M ; Deshmukh H ; Ahlqvist E ; Colhoun H ; Isomaa B ; Rossing P ; Groop L ; Lyssenko V 2013
Diabetologia

Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study

Hove KD ; Brons C ; Faerch K ; Lund SS ; Petersen JS ; Karlsen AE ; Rossing P ; Rehfeld JF ; Vaag A 2013
Diabetologia

Impact of early detection and treatment of diabetes on the 6- year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster- randomised study

Charles M ; Fleischer J ; Witte DR ; Ejskjaer N ; Borch-Johnsen K ; Lauritzen T ; Sandbaek A 2013